8 - 10 November 2018
Madrid, Spain

Sponsorship and Exhibition

Satellite Symposia


Thursday, 8 November 2018


Satellite Symposium Sanofi-Genzyme and RegeneronSAGZ Regeneron Logo 600px
Type 2 Inflammation in Severe Asthma: Clinical and Therapeutic Implications

18:15 – 19:15
Room: Zaragoza I & II
Chair: Santiago Quirce, Spain
•    Welcome and Introductions.  Santiago Quirce, Spain
•    Defining Severe Asthma.  Zuzana Diamant, The Netherlands
•    Type 2 Asthma: What Is it and What Mediators Drive It?  Santiago Quirce, Spain
•    Interactive Session: Identifying Type 2 Asthma in Clinical Practice.  G. Walter Canonica, Italy
•    Closing Remarks and Panel Q&A.  Santiago Quirce, Spain


Friday, 9 November 2018

Satellite Symposium Novartis

New approaches in severe allergic asthma


13:15 – 14:15
Room: Zaragoza I & II
Chair: Ignacio Dávila, Spain
•    Defining the severe allergic asthma patient candidate to biologics.  Santiago Quirce, Spain
•    Component resolved diagnosis in severe allergic asthma.  Olga Luengo, Spain


Satellite Symposium ALK
Relevant outcomes in allergic asthma
 
18:00 – 19:00
Room: Zaragoza I & II
Chair: Eike Wüstenberg, Germany
•    Early identification of asthma deterioration for modifying or preventing severe exacerbations. A clinical trial perspective.  Göran Eriksson, Sweden
•    Can we influence the natural course of asthma in routine care?  Eike Wüstenberg, Germany